Intravenous Immunoglobulin Market Size Worth USD 24.76 Billion in 2032 | Emergen Research Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the...

Intravenous Immunoglobulin Market Sales to reach US$ 25,884 Million by 2032; Immunodeficiency Disease Treatment to comprise 20% of total Uptake: Persistence Market Research New York, Dec. 22, 2022 (GLOBE NEWSWIRE) -- As per a study conducted by Persistence Market Research, the global intravenous immunoglobulin market is anticipated to secure US$ 12,000 Million in 2022,...

Intravenous Immunoglobulin Market Size Hit $18.67Bn, Globally, by 2028 Growing at 7.6% CAGR | Exclusive Report by The Insight Partners New York, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on Intravenous Immunoglobulin Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type...

Intravenous Immunoglobulin (IVIG) Market will have opportunities worth US$14,923.2 million by 2024, TMR Albany, NY, April 23, 2018 (GLOBE NEWSWIRE) -- Transparency Market Research estimates that the global intravenous immunoglobulin market, which was valued at US$8,419.7 million in 2017, is projected...

Intravenous Immunoglobulin (IVIG) Market Will Grow Rapidly Owing To Enhanced Demand In Immunoglobulin Replacement Therapies Till 2022: Grand View Research, Inc. San Francisco, May 18, 2016 (GLOBE NEWSWIRE) -- Global intravenous immunoglobulin market is expected to reach USD 10.9 billion by 2022, according to a new study by Grand View Research, Inc. ...